Cumberland Pharmaceuticals (CPIX) Treasury Shares (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Treasury Shares across 17 years of filings, most recently posting $20245.0 for Q1 2026.

• Treasury Shares for Q1 2026 came in at $20245.0, down 62.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $20245.0 (down 62.4% YoY), and the FY2025 annual result was $58947.0, down 82.62% from the prior year.
• Treasury Shares came in at $20245.0 for Q1 2026 at Cumberland Pharmaceuticals, down from $58947.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $395751.0 in Q4 2022 to a low of $1800.0 in Q2 2025.
• The 5-year median for Treasury Shares is $86829.0 (2023), against an average of $147103.5.
• Across the five-year window, Treasury Shares soared 89.86% in 2022 and slumped 97.66% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Treasury Shares stood at $395751.0 in 2022, then sank by 34.16% to $260566.0 in 2023, then jumped by 30.18% to $339200.0 in 2024, then plunged by 82.62% to $58947.0 in 2025, then slumped by 65.66% to $20245.0 in 2026.
• The last three Treasury Shares figures came in at $20245.0 (Q1 2026), $58947.0 (Q4 2025), and $58947.0 (Q3 2025), per Business Quant data.